Taysha Gene Therapies, Inc.
Extract: Charter Amendment (Plain English Desc) from a 8-K on 11/15/2023   Download
SEC Document
SEC Filing

On November 15, 2023, Taysha Gene Therapies, Inc. (the “Company”) filed with the Secretary of State of the State of Delaware a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended to date, to increase the authorized number of shares of the Company’s common stock from 200,000,000 shares to 400,000,000 shares.